[November 27, 2015]

Research and Markets: Global Visceral Pain Pipeline Review, H2 2015 - 12 Companies & 19 Drug Profiles

Research and Markets (http://www.researchandmarkets.com/research/h2zfrx/visceral_pain) has announced the addition of the "Visceral Pain - Pipeline Review, H2 2015" report to their offering.

This report provides comprehensive information on the therapeutic development for Visceral Pain, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Visceral Pain and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective countr strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies Involved in Therapeutics Development

• Addex Therapeutics Ltd
• Amorepacific Corporation
• Aros Pharma ApS
• Astellas Pharma Inc.
• Echo Pharmaceuticals B.V.
• GIcare Pharma Inc
• Grunenthal GmbH
• Hydra Biosciences, Inc.
• Nektar Therapeutics
• Neurim Pharmaceuticals Ltd
• Proteus (News - Alert) SA
• RDD Pharma Ltd.

Drug Profiles

• ADX-71441
• ASP-7663
• dronabinol
• GIC-1001
• GIC-1002
• HC-030031
• neosaxitoxin
• NeuP-12
• nifedipine
• NKTR-195
• PAC-14028
• piromelatine
• PPC-5650
• PR-38
• RO-656570
• Small Molecule to Block Nav1.9 Channel for Pain
• Small Molecules to Antagonize TRPM8 for Overactive Bladder and Pain
• Synthetic Peptides to Activate OXTR for Oncology and Abdominal Pain
• URB-937

For more information visit http://www.researchandmarkets.com/research/h2zfrx/visceral_pain

View source version on businesswire.com: http://www.businesswire.com/news/home/20151127005142/en/

[ Back To TMCnet.com's Homepage ]